New DirectorT cell therapy developer Crescendo Biologics Ltd (Crescendo) has named Eva-Lotta Allan Non-Executive Director of the company. The former CFO of Immunocore brings in over 30 years experience in the … more ➔
Dirk Kersten joins Forbion as General Part...Forbion, a European life science venture capital firm, today announces that Dirk Kersten will join as a General Partner on October 1st, 2018. more ➔
Cell Medica Appoints Julia P. GregoryCell Medica, today announced the appointment of Julia P. Gregory as a Non-Executive Director and Audit Chair of the Companys Board of Directors. more ➔
Tigenix announces change in Board of Direc... Tigenix NV, a biopharmaceutical company focused on exploiting the anti-inflammatory properties of allogeneic stem cells, today announces that Eduardo Bravo will depart the board of directors and his … more ➔
Josh Muntner joins Mesoblast as CFOJosh Muntner has been appointed Chief Financial Officer of Mesoblast. He will be based in New York. more ➔
PureTechs Gelesis Appoints Harry Leider...PureTech Health plc announced today that its affiliate, Gelesis, has appointed Harry Leider, MD, MBA, former Chief Medical Officer and Group Vice President of Walgreens, as Chief Medical Officer. more ➔
Hikma appoints Henriette NielsenHikma Pharmaceuticals PLC announces the appointment of Henriette Nielsen to the newly created role of Chief Transformation Officer. more ➔
Sygnature Discovery appoints Dr Bill Marat...Sygnature Discovery, thas appointed Dr Bill Marathias as Vice President of Business Development for the US to assist with the companys international growth plans. more ➔
Bavarian Nordic to appoint Henrik Juuel as...Bavarian Nordic A/S today announced the appointment of Henrik Juuel to the position of Executive Vice President and Chief Financial Officer. Mr. Juuel is currently the CFO of Orexo AB. more ➔
Rainer Boehm joins Nordic Nanovector Board...Nordic Nanovector ASA today announces that Rainer Boehm, MD was elected as a member of its Board of Directors at the companys Annual General Meeting on 30 May 2018. more ➔